The Phase-III human trials of indigenous Covid-19 vaccine Covaxin began at All India Institute of Medical Science (AIIMS) in New Delhi on Thursday.

M V Padma Srivastava, the chief of Neurosciences Centre and three other volunteers received the first dose of Covaxin. Around 15,000 volunteers at AIIMS will be given the shot as part of the clinical trials.